Tweenvest Stocks

Quantum BioPharma Ltd. (CNSX: QNTM)

Health Care · Pharmaceuticals · CA

CA$4.48

-4.68% today · -81.2% 1Y

Quantum BioPharma Ltd. (CNSX: QNTM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.61M and employs 17 people.

Over the last twelve months the share price has lost 81.2%, trading between 2.85 and 28.59.

Tweenvest scores Quantum BioPharma Ltd. across four factors: quality 29/100. Its strongest factor is quality.

QNTM price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$27.61M
Revenue (TTM)
P/E
EPS
-5.35
Dividend yield
Beta (5Y)
0.43
52-week high
CA$28.59
52-week low
CA$2.85
Avg volume (3M)
Shares outstanding
8.09M
Employees
17
Next earnings

About Quantum BioPharma Ltd.

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.

ISIN
CA74764Y2050
Founded
1998
Listed since
May 29, 2018
Exchange
Canadian National Stock Exchange
Currency
CAD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.10T$1,199.25-2.79%
Johnson & JohnsonNYSE: JNJ$658.24B$270.42-1.00%
Merck & Co., Inc.NYSE: MRK$385.99B$154.02-1.55%
Roche Holding AGSWX: ROP$371.62BCHF368.30-1.47%
Novartis AGSWX: NOVN$303.81BCHF128.34+1.25%
AstraZeneca PLCLSE: AZN$263.84B£122.34-1.94%
Novo Nordisk A/SCPSE: NOVO B$212.51BDkr307.80+2.86%
Pfizer Inc.NYSE: PFE$162.84B$28.40-0.60%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.